Close Menu

Oh, IP

Illumina is suing Life Technologies for allegedly infringing one of its bead arrays patents, Bloomberg reports. Illumina says Life Tech's Ion Personal Genome Machine and Ion OneTouch System infringe its US Patent No. 7,060,431, which covers a method of "making and decoding of array sensors with microspheres," as the company said in its complaint.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.